Elevating theranostics:The emergence and promise of radiopharmaceutical cell-targeting heterodimers in human cancersOA
Elevating theranostics:The emergence and promise of radiopharmaceutical cell-targeting heterodimers in human cancers
Claudia Chambers;Broc Chitwood;Charles J.Smith;Yubin Miao
Molecular Imaging and Theranostics Center,Columbia,Missouri,USA||Research Division,Harry S.Truman Memorial Veterans'Hospital,Columbia,Missouri,USA||Department of Chemistry,University of Missouri,Columbia,Missouri,USAMolecular Imaging and Theranostics Center,Columbia,Missouri,USAMolecular Imaging and Theranostics Center,Columbia,Missouri,USA||Research Division,Harry S.Truman Memorial Veterans'Hospital,Columbia,Missouri,USA||Department of Radiology,University of Missouri School of Medicine,Columbia,Missouri,USA||University of Missouri Research Reactor Center,University of Missouri,Columbia,Missouri,USADepartment of Radiology,University of Colorado Denver,Aurora,Colorado,USA
heterodimerheterobivalenthybrid peptidePSMAGRPRαvβ3SSTMSH
heterodimerheterobivalenthybrid peptidePSMAGRPRαvβ3SSTMSH
《智能影像学（英文）》 2024 (2)
128-155,28
NIH Research Evaluation and Commercilization Hub,Grant/Award Number:1U01HL152410USVA Medical Research Service,Grant/Award Number:I01 BX00096409National Institutes of Health,Grant/Award Numbers:R01CA269221,R01CA225837
评论